Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species-Reference-Cited by-同舟云学术

Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species

Published:2022-04-16 Issue:8 Volume:6 Page:2090-2104
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Yukawa‐Muto Yoshimi,Kamiya Tomonori,Fujii Hideki,Mori Hiroshi,Toyoda Atsushi,Sato Ikuya,Konishi Yusuke,Hirayama Akiyoshi,Hara Eiji,Fukuda Shinji,Kawada Norifumi,Ohtani Naoko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1954

Reference36 articles.

1. The pharmabiotic approach to treat hyperammonemia;Nutrients,2018

2. Hepatic encephalopathy: classification and treatment;J Hepatol,2018

3. Alterations of the human gut microbiome in liver cirrhosis;Nature,2014

4. TLR4 enhances TGF‐beta signaling and hepatic fibrosis;Nat Med,2007

5. Microbiome therapeutics for hepatic encephalopathy;J Hepatol,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis;Journal of Gastroenterology and Hepatology;2024-01-17

2. Viral Liver Disease and Intestinal Gut–Liver Axis;Gastrointestinal Disorders;2024-01-08

3. Microbial ureases;Ureases;2024

4. Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy;Journal of Clinical Medicine;2023-10-31

5. Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier;Therapeutics and Clinical Risk Management;2023-10